Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Launches Safe Use Initiative; Details To Evolve Through Stakeholder Input

This article was originally published in The Pink Sheet Daily

Executive Summary

Vast scope of project - which will examine everything from operating room procedures to pharmacy leaflets - contrasts with "small" goals for the first year.
Advertisement

Related Content

Outpatient Rx Safety Meeting To Spotlight Health Literacy, Provider Communication
FDA Safety Meetings: Outpatient Drugs, Hypoglycemia Getting Limelight
CDER Outreach Coordinator’s First Task Is Safe Use Initiative
The Limits Of REMS: Opioid Debate Shows Shortcomings Of New FDA Powers
The Limits Of REMS: Opioid Debate Shows Shortcomings Of New FDA Powers
Medication Errors: FDA Renews Focus On Drug Packaging As Part Of Prevention Campaign
Medication Errors: FDA Renews Focus On Drug Packaging As Part Of Prevention Campaign
Regulatory News In Brief
FDA Faces “Daunting” Mission As It Partners With Doctors For Safe Rx Use
FDA Faces “Daunting” Mission As It Partners With Doctors For Safe Rx Use

Topics

Advertisement
UsernamePublicRestriction

Register

PS068832

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel